visualizations
Carr, Amy, PharmD, BCIDP
Overview
overview
- Amy L. Carr, PharmD is a board-certified infectious diseases pharmacist practicing as the Clinical Pharmacy Manager and PGY1 Pharmacy Residency Program Director at AdventHealth Orlando. She earned her B.S. in Chemistry from the University of Arkansas followed by her Doctor of Pharmacy degree from University of Florida College of Pharmacy – Gainesville. Dr. Carr completed PGY1 Pharmacy Residency at Baylor University Medical Center in Dallas, Texas, followed by a PGY2 Infectious Diseases Residency at Ascension Dell Seton Medical Center in Austin, Texas. Dr. Carr is passionate about ensuring patients receive the best antimicrobial regimens with emphasis on effective antibiotic selection, optimal dosing, and risk reduction (such as therapeutic drug monitoring, screening for drug-drug interactions, etc.). She loves that her role gives her the opportunity to share her passion for ID/antimicrobial stewardship with colleagues in nearly every discipline across the hospital. Her clinical and research interests include antimicrobial PK/PD, mechanisms of gram negative resistance, early postmarketing experience with new antimicrobials, and antimicrobial stewardship in large health systems.
Affiliation
Member of
-
Clinical Program
-
Research Department
Publications
Most Recent Publications
-
2024Analytical and clinical validation of direct detection of antimicrobial resistance markers by plasma microbial cell-free DNA sequencing. JOURNAL OF CLINICAL MICROBIOLOGY.Full Text via DOI: 10.1128/jcm.00425-24 PMID: 39194269
-
2024A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022. OPEN FORUM INFECTIOUS DISEASES.Full Text via DOI: 10.1093/ofid/ofad687 PMID: 38434614
-
2024Epidemiology and treatment of invasive Bartonella spp. infections in the United States. INFECTION.Full Text via DOI: 10.1007/s15010-024-02177-1 PMID: 38300353
-
2024A PHARMACIST-DRIVEN MRSA PCR ALGORITHM IN CRITICALLY ILL VS NONCRITICALLY ILL PNEUMONIA PATIENTS. CRITICAL CARE MEDICINE.
-
2023Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial Stenotrophomonas maltophilia Infections in Hospitalized Patients. ANNALS OF PHARMACOTHERAPY.Full Text via DOI: 10.1177/10600280231201850 PMID: 37776160
-
2022Pharmacist-Driven Methicillin-Resistant S. aureus Polymerase Chain Reaction Testing for Pneumonia. ANNALS OF PHARMACOTHERAPY.Full Text via DOI: 10.1177/10600280221121144 PMID: 36039495
-
2022PHARMACIST-DRIVEN METHICILLIN-RESISTANT S AUREUS POLYMERASE CHAIN REACTION TESTING FOR PNEUMONIA. CRITICAL CARE MEDICINE. 341-341.
-
2021Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. CLINICAL INFECTIOUS DISEASES. E1754-E1757.Full Text via DOI: 10.1093/cid/ciaa1847 PMID: 33313656
-
2021Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury. OPEN FORUM INFECTIOUS DISEASES.Full Text via DOI: 10.1093/ofid/ofab170 PMID: 34642634
-
2021ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLOS ONE. 16.Full Text via DOI: 10.1371/journal.pone.0249038 PMID: 33765049
-
2018Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature. PHARMACOTHERAPY. 38:1216-1228.Full Text via DOI: 10.1002/phar.2188 PMID: 30300441
-
2018Evaluating predictors of invasive candidiasis in patients with and without candidemia on micafungin.. Proceedings (Baylor University. Medical Center). 31:30-34.Full Text via DOI: 10.1080/08998280.2017.1396164 PMID: 29686548
Background
Full Name
- Amy Carr, PharmD, BCIDP
Education
- University of Florida College of Pharmacy – Gainesville
Residency
- Baylor University Medical Center in Dallas, Texas Ascension Dell Seton Medical Center in Austin, Texas
Contact
primary email
- Research.Institute@AdventHealth.com